Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1355)	2/25/1999 12:10:00 AM
From: John R. Sashko	Read Replies (1) \| Respond to of 2539

Anthony, Not much comparison between Celebrex and Synvisc. Synvisc is an injectable for arthritis of the knees. Celebrex is an oral agent for arthritis in any joint.It will mostly be utilized by specialists. Rheumatology more than Orthopedics. I'm sure that Synvisc will have its niche. Results are variable and doesn't appear to last more than 1 year. Good choice to delay that knee replacement or if a patient is not a candidate for surgery due to multiple medical problems. John